Richard M. Sherry

Best Publications

• Cancer regression in patients after transfer of genetically engineered lymphocytes

  Richard A. Morgan;Mark E. Dudley;John R. Wunderlich;Marybeth S. Hughes

  3824
  Citations

• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  Mark E. Dudley;John R. Wunderlich;Paul F. Robbins;James C. Yang

  3729
  Citations

• A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

  James C. Yang;Leah Haworth;Richard M. Sherry;Patrick Hwu

  3529
  Citations

• Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy

  Steven A. Rosenberg;James C. Yang;Richard M. Sherry;Udai S. Kammula

  2587
  Citations

• Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

  Mark E. Dudley;John R. Wunderlich;James C. Yang;Richard M. Sherry

  2110
  Citations

• Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

  James N. Kochenderfer;Mark E. Dudley;Sadik H. Kassim;Robert P.T. Somerville

  2096
  Citations

• Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

  Paul F. Robbins;Richard A. Morgan;Steven A. Feldman;James C. Yang

  1933
  Citations

• Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

  Giao Q. Phan;James C. Yang;Richard M. Sherry;Patrick Hwu

  1911
  Citations

• B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

  James N. Kochenderfer;Mark E. Dudley;Steven A. Feldman;Wyndham H. Wilson

  1741
  Citations

• Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

  Laura A. Johnson;Richard A. Morgan;Mark E. Dudley;Lydie Cassard

  1711
  Citations

• Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

  Mark E. Dudley;James C. Yang;Richard Sherry;Marybeth S. Hughes

  1663
  Citations

• Phase 2 trial of single agent ipilimumab (Anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma

  Richard E. Royal;Catherine Levy;Keli Turner;Aarti Mathur

  1537
  Citations

• Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

  Richard A. Morgan;Nachimuthu Chinnasamy;Daniel Abate-Daga;Alena Gros

  1512
  Citations

• T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis

  Maria R. Parkhurst;James C. Yang;Russell C. Langan;Mark E. Dudley

  1217
  Citations

• Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

  Peter Attia;Giao Q. Phan;Ajay V. Maker;Michael R. Robinson

  1146
  Citations

• The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

  Yair Herishanu;Patricia Pérez-Galán;Delong Liu;Angélique Biancotto

  1042
  Citations

• Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal Cancer

  James C. Yang;Richard M. Sherry;Seth M. Steinberg;Suzanne L. Topalian

  1001
  Citations

• Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

  James C. Yang;Marybeth Hughes;Udai Kammula;Richard E Royal

  979
  Citations

• Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4

  Kimberly E. Beck;Joseph A. Blansfield;Khoi Q. Tran;Andrew L. Feldman

  939
  Citations

• A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

  Paul F. Robbins;Sadik H. Kassim;Thai Lan N. Tran;Jessica S. Crystal

  889
  Citations